We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA Guidelines Address Trials for PAH, Cystic Fibrosis Drugs
EMEA Guidelines Address Trials for PAH, Cystic Fibrosis Drugs
December 9, 2009
In an ongoing effort to help sponsors develop drugs for specific conditions, the European Medicines Agency (EMEA) has released two guidelines aimed at testing drugs for pulmonary arterial hypertension (PAH) and cystic fibrosis.